•
Atypical hemolytic uremic syndrome (AHUS) is a rare disease characterized by complement over-activation and represents an estimated 5-10% of all hemolytic uremic syndrome cases. 1-2 -Affects approximately 2 per million people in the United States. 3 -Characterized by systemic thrombotic microangiopathy (TMA) which causes blood clots in small vessels throughout the body. These blood clots can lead to stroke, heart attack, kidney failure, and other conditions. 2,4-5 • AHUS may be of genetic origin or acquired and shows no variation by race or gender. 1 -Although AHUS may develop at any age, it most commonly develops in children under two years of age. 6 
Prognosis is poor in patients diagnosed with AHUS with 36-48% of children and 64-67% of adults expiring or reaching end stage renal disease (ESRD) within three to five years after onset. 5, 7 • Treatment for patients with AHUS generally includes plasma exchange or infusion or administration of eculizamab complement inhibitor. defined through the use of ICD-9 codes and included: renal disease, diabetes, chronic pulmonary disease, congestive heart failure, malignancy/tumor, cardiovascular disease, liver disease, ulcer, rheumatic disease, plegia, and dementia.
HOSPITAL-BASED UTILIZATION IN PATIENTS WITH ATYPICAL HEMOLYTIC UREMIC SYNDROME

•
Measures of resource utilization included number of inpatient discharges and hospital-based outpatient visits and inpatient length of stay. Statistical Analysis • All statistical tests were conducted using SAS version 9.2. Alpha was set at .05 for tests of significance.
Multivariate logistic regression and negative-binomial multivariate regression was used to identify significant drivers for same-hospital readmission and inpatient length of stay, respectively. -Selected covariates included age and gender, hospital characteristics, and comorbidities.
Study Limitations
• These data represent only utilization within the hospital setting.
• Patients with AHUS consume a significant amount of healthcare resources.
• More than half of the hospital visits for patients with AHUS had a comorbidity of renal disease.
• Although less than 25% of the hospital utilization occurs in the inpatient setting, average length of stay is more than 16 days and readmission rates are over 14%.
•
Treatments varied between the inpatient and outpatient setting with most inpatients receiving transfusion or dialysis while eculizumab administration was most common in outpatients.
Many outpatient visits did not include a treatment.
Further research is required to understand the effect of interventions/treatments on mitigating the progress of this disease.
Patient Demographics
• The sample population included 6,571 visits representing 2,089 individual patients.
•
More than 76.0% of the hospital visits occurred in the outpatient setting.
• Among the outpatient visits 54.7% had a primary diagnosis of hemolytic uremic syndrome and 16.9% had end stage renal disease.
The mean age of the sample was 23 years with 59.3% under the age of 18 and 61% female.
• Patient demographics are shown in Table 1 .
Procedures and Treatments
• The most common inpatient procedures are shown in Figure 1 .
•
In the inpatient setting the most common treatment was transfusion (55.9%) followed by dialysis (34.1%). A small number of patients were treated with eculizumab (3.2%) and transplants (2.5%).
• Eculizumab was the most prevalent treatment in the outpatient setting (7.5%). Transfusions occurred in 4.5% of the patients.
Comorbidities
• Charlson comorbidities for this population, outlined in Table 3 , included renal disease (56.2%), congestive heart failure (11.1%), chronic pulmonary disease (10.0%), and diabetes without chronic complications (8.0%).
•
Other common comorbidities in the inpatient population included hypertension (28.0%), pneumonia (12.0%), diarrhea (11.4%), severe neurological disorders (7.0%), pancreatitis (6.6%), and thrombocytopenia (5.8%). Figure 2 and include transfusion procedures and the presence of a malignancy. 
Hospital Characteristics
• More than 60% of the visits occurred in teaching facilities and facilities with 300 beds or more.
• Detailed hospital characteristics can be found in Table 2 .
Readmission
• Same-hospital readmissions occurred in 14.5% of the inpatient sample. 
